Kristina Simmons
Founder and Managing Partner @ Overwater Ventures
Palo Alto, United States
Kristina Simmons is a seed investor at Overwater Ventures in Palo Alto focused on Biotechnology and Biopharma. Kristina Simmons is based out of Palo Alto, California, and is the Founder and Managing Partner of Overwater Ventures. Kristina previously worked at Khosla Ventures as a Chief of Staff and Investor. Kristina Simmons attended the University of Michigan
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Kristina Simmons invests in
Stages Kristina Simmons invests in
Countries Kristina Simmons invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (50%)
- Biopharma 2 (33%)
- Health Care 2 (33%)
- Medical 1 (17%)
- Genetics 1 (17%)
Stage
- Seed 3 (50%)
- Series C 1 (17%)
- Funding Round 1 (17%)
- Venture - Series Unknown 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Adaptyx Biosciences develops wearable sensors. | $14M / Seed / Oct 20, 2025 | ||
| BeSound provides mammograms, screening and biopsy services to help the women to detect cancers earlier. | $6.8M / Seed / Sep 30, 2025 | ||
| Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives.Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. Gameto aims to changethat.Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, they have developed a platform to produce female reproductive cell lines. They use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Their team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Gameto's first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno. | $44M / Series C / Aug 12, 2025 | ||
| Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures, aiming to enhance the efficiency and accessibility of in vitro fertilization (IVF). Its solutions focus on automating complex embryology lab processes, such as egg vitrification and embryo warming, to improve consistency and reducecosts. The company's DaVitri platform is designed to standardize these procedures, potentially increasing oocyte survival rates and decreasing the number of IVF cycles needed. | $20.6M / Venture - Series Unknown / Apr 24, 2025 | ||
| Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | Mar 19, 2025 | ||
| Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | $4.5M / Seed / Mar 19, 2025 |
Co-Investors
About Overwater Ventures
Overwater Ventures is an investment firm.
Overwater Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kristina Simmons
Founder and Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kristina Simmons invest in?
Kristina Simmons invests primarily in Biotechnology, Biopharma and Health Care startups, most often at Seed and Series C stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kristina Simmons?
Public channels for Kristina Simmons include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kristina Simmons last invest?
The most recent investment recorded for Kristina Simmons closed in Oct 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
